StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix gross margin

Gross margin is gross profit as a percentage of revenue.

Renalytix's gross margin for the twelve months ending Sep 30, 2024 was 12.7%. For fiscal 2024 it was 6.8%, against 21.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Jun 30, 20246.8%−14.3
FY2023Jun 30, 202321.2%−8.3
FY2022Jun 30, 202229.4%−13.0
FY2021Jun 30, 202142.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2025CQ3 2024Sep 30, 202419.2%+28.5
Q4 FY2024CQ2 2024Jun 30, 20246.1%+36.1
Q3 FY2024CQ1 2024Mar 31, 2024-12.3%−29.0
Q2 FY2024CQ4 2023Dec 31, 202332.3%−8.1
Q1 FY2024CQ3 2023Sep 30, 2023-9.4%−37.5
Q4 FY2023CQ2 2023Jun 30, 2023-29.9%−46.6
Q3 FY2023CQ1 2023Mar 31, 202316.7%+1.1
Q2 FY2023CQ4 2022Dec 31, 202240.4%−1.4
Q1 FY2023CQ3 2022Sep 30, 202228.2%−24.7
Q4 FY2022CQ2 2022Jun 30, 202216.7%+8.3
Q3 FY2022CQ1 2022Mar 31, 202215.6%−57.1
Q2 FY2022CQ4 2021Dec 31, 202141.8%+6.0
Q1 FY2022CQ3 2021Sep 30, 202152.9%–
Q4 FY2021CQ2 2021Jun 30, 20218.5%–
Q3 FY2021CQ1 2021Mar 31, 202172.7%–
Q2 FY2021CQ4 2020Dec 31, 202035.8%–

More Renalytix figures

See a number that looks wrong?